| Ziftomenib studied in …STUDIED_INderived16 of 16show fewer |
|---|
| → studied in | NCT06769490Phase 1 · recruiting Dose Escalation and Expansion of Ziftomenib in Combination With Quizartinib in Acute Myeloid Leukemia · 16 trials list this drug (15 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06397027Phase 1 · recruiting A Phase I Study Investigating the Combination of the Ziftomenib, Venetoclax and Azacitidine in Pediatric Relapsed and Refractory Acute Leukemias · 16 trials list this drug (15 active) | — | — | Acute Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06930352Phase 2 · recruiting Ziftomenib for the Treatment of Patients With NPM1 Mutated or KMT2A Rearranged Acute Myeloid Leukemia Not Eligible for Standard Therapy · 16 trials list this drug (15 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07411586Phase 1 · active not recruiting Phase 1/1b Trial Of Olutasidenib And Ziftomenib For NPM1 And IDH1 Co-Mutated Acute Myeloid Leukemia · 16 trials list this drug (15 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06001788Phase 1 · recruiting Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia · 16 trials list this drug (15 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm,Leukemia,Acute Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07007312Phase 3 · recruiting Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML · 16 trials list this drug (15 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05738538available Expanded Access to Ziftomenib · 16 trials list this drug (15 active) | — | — | Acute Lymphoblastic Leukemia,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06448013Phase 1 · recruiting A Phase I Study Investigating the Combination of the Menin Inhibitor Ziftomenib With Venetoclax and Gemtuzumab in Pediatric Patients With Acute Myeloid Leukemia · 16 trials list this drug (15 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05848687Phase 1/Phase 2 · recruiting TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II · 16 trials list this drug (15 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07623616Phase 2 · recruiting A Phase 2 Clinical Study of Ziftomenib in Patients With Relapsed or Refractory NPM1-Mutated Acute Myeloid Leukemia · 16 trials list this drug (15 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04067336Phase 1/Phase 2 · active not recruiting First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia · 16 trials list this drug (15 active) | — | — | Malignant Neoplasm,Acute Lymphoblastic Leukemia,Acute Leukemia of Ambiguous Lineage+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06440135Phase 1 · recruiting Ziftomenib Maintenance Post Allo-HCT · 16 trials list this drug (15 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05735184Phase 1 · recruiting A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML · 16 trials list this drug (15 active) | — | — | Myeloid Sarcoma,Acute Myeloid Leukemia,Acute Myeloid Leukemia with NPM1 Mutation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06655246Phase 1 · recruiting A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST) · 16 trials list this drug (15 active) | — | — | Gastrointestinal Stromal Tumor,Malignant Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07355335Phase 1 · not yet recruiting Ziftomenib + Mezigdomide in Adolesc. and Adults w/ R/R AML · 16 trials list this drug (15 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06376162Phase 1 · recruiting Ziftomenib in Combination With Chemotherapy for Children With Relapsed/Refractory Acute Leukemia · 16 trials list this drug (15 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |